

Comment Info: =================

General Comment:We submit a letter signed by several distiguished individuals representing both industry and academia. This letter is sent in response to the draft guidance issued by the FDA: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology (Document ID FDA-2010-D-0530-0002)

